CD8A and neoplasm: Furthermore, YTHDF1-knockdown mice had stronger response to tumor antigen-specific CD8+ T cells than wild-type mice; knockdown of YTHDF1 in classic DC cells enhanced the cross-presentation of tumor antigens in vivo and the cross-activation of CD8+ T cells (30, 40).